Status:
RECRUITING
Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)
Lead Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Conditions:
Infertilities
Embryo Transfer
Eligibility:
FEMALE
18-41 years
Phase:
PHASE4
Brief Summary
In pregnancies achieved through programmed frozen embryo transfer cycle (PC-FET) and modified natural frozen embryo transfer (mNC-FET), to determine whether there are differences in endothelial and pl...
Eligibility Criteria
Inclusion
- Female patients 18- 37 years old (both included) at the time of oocyte retrieval and less than 41 years of age at the time of embryo transfer.
- Regular menstrual cycles between 24 and 35 days.
- Availability of cryopreserved blastocysts from own gametes
- Indication for single embryo transfer.
- Patients who will be included in the LUTI study are candidates for either of the two procedures under study, and will have no contraindications for either procedure.
Exclusion
- Recurrent pregnancy loss (3 or more).
- Recurrent implantation failure in previous IVF treatments (3 or more unsuccessful embryo transfers). .
- Diagnosis of polycystic ovarian syndrome, diabetes mellitus, chronic arterial hypertension, maternal heart disease and autoimmune diseases (Systemic Lupus Erythematosus (SLE) or Antiphospholipid syndrome (APS)).
- Active treatment with aspirin, heparin or other anticoagulant therapy, antihypertensives or other drugs used to treat circulation or coagulation disorders .
- Indication for PGT (Preimplantation Genetic Testing).
- Multiple pregnancy.
Key Trial Info
Start Date :
February 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2026
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT06896617
Start Date
February 1 2025
End Date
December 20 2026
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laura Burunat
Barcelona, Spain, Spain, 08036